Tong-xin-luo capsule inhibits left venticular remodeling in spontaneously hypertensive rats by enhancing PPAR-γ expression and suppressing NF-κB activity

Chinese Medical Journal

Volumn 121, Issue 2, 2008, Pages 147-154

  Bu, Pei Li ^a,b   Zhao, Xue Qiang ^a,b   Wang, Li Ling ^c   Zhao, Yu Xia ^b   Li, Chuan Bao ^a,b   Zhang, Yun ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Chinese herbal; Inbred spontaneously hypertensive rat; Nuclear factor kappa B; Peroxisome proliferator activated receptors; Ventricular remodeling

Indexed keywords

BETA ACTIN; CHINESE DRUG; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HETERODIMER; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN P50; SODIUM CHLORIDE; TONG XIN LUO; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; BODY WEIGHT; CONTROLLED STUDY; DRUG CAPSULE; DRUG MECHANISM; GENE EXPRESSION REGULATION; HEART LEFT VENTRICLE; HEART RATE; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS INHIBITION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; WESTERN BLOTTING; WISTAR KYOTO RAT;

EID: 39049153969     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200801020-00011     Document Type: Article

References (22)

1. Kong Q, Yang XC, Liu XL. Effects of tongxinluo on the myocardial inflammatory reaction and expression of tumor necrosis factor-alpha in rats with myocardial infarction. Chiq J Integ Trad West (Chin) 2006; 26: 545-549.
2. Li Z, Yang YJ, Qin XW, Ruan YM, Chen Y, Meng L, et al. Effects of Tong-xin-luo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aotic atherosclerosis and molecular mechanism: a comparative study with rabbits. Nat Med J China (Chin), 2006; 86: 3146-3150.
3. Tang YS, Cui X. The effect of Tong Xin. Luo on vascular remodeling after angioplasty in rabbits. Chin J Cardio (Chin) 2002; 32: 1147-1149.
4. Liu JC, Cheng TH, Lee HM, Lee WS, Shih NL, Chen YL, et al. Inhibitory effect of trilinolein on angiotensin II-induced cardiomyocyte hypertrophy. Eur J Pharmocol 2004; 404: 1-8.
5. Iturbe BR, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND. Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther 2005; 315: 51-57.
6. Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 2002; 91: 1103-1113.
7. Asakawa M, Takano H, Nagai T, Uozumi H, Hasegawa H, Kubota N, et al. Peroxisome proliferators activated receptor γ plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo. Circulation 2002; 105: 1240-1246.
8. Tetsuya S, Hiroyuki T, Shunj H. Pioglitazone, a peroxisome proliferator-activated receptor agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2002; 6: 3126-3132.
9. Frantz S, Fraccarollo D, Wagner H, Behr TM, Jung P, Angermann CE. Sustained activation of nuclear factor kappa B and activator protein-1 in chronic heart failure. Cardiovasc Res 2003; 57; 749-756.
10. Swaney JS, Roth DM, Olson ER, Naugle JE, Meszaros JG, Insel PA. Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylylcyclase. Proc Natl Acad Sci USA 2005; 102: 437-442.
11. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve diseases. Circ Res 2004; 95: 253-260.
12. Wang XF, Gao GD, Liu J, Guo R, Lin YX, Chu YL, et al. Identification of differentially expressed genes induced by angiotension II in rat cardiac fibroblasts. Clin Exp Pharmacol Phsiol 2006; 33: 41-46.
13. Wang HJ, Xie LD, Yao EH. Effect of tongxinluo on myocardial fibrosis in Spontaneously Hypertensive Rats. Chin J Integ Trad West (Chin) 2003; 1: 189-190.
14. Chen W, Gu RY, Zhu P. Experimental study on depressing ventricular remodeling of rats by regulation of β-adrenoreceptor pathway with Tongxinluo. J Diffic and Compl Cas 2002; 1: 12-14.
15. Qian HY, Yang YJ, Huang J, Gao RL, Dou KF, Yang GS, et al. Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts. Chin Med J 2007; 120: 1416-1425.
16. Gupta S, Purcell NH, Lin A, Sen S. Activation of nuclear factor kappaB is necessary for myotrophin-induced cardiac hypertrophy. J Cell Biol 2002; 159: 1019-1028.
17. Gomez PF, Pillinger MH, Attur M, Marjanovic N, Dave M, Park J, et al. Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of Individual NF-κB subunits (P65, P50) in stimulated rheumatoid synovial fibroblasts. J Immunol 2005; 175: 6924-6930.
18. Strayhom WD, Wadzinski BE. A novel in vivo assay for deubiquitination of 1 kappa B alpha. Arch Biochem Biophys 2002; 400: 76-84.
19. Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S. Ligands of the peroxisome proliferators activated proliferators activated receptors (PPAR- and PPAR-α) reduce myocardial infarct size. FASEB J 2002; 16: 1027-1040.
20. Diep QN, Benkirane K, Amiri F, Cohn JS, Endemann D. PPAR activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats. J Mol Cell Cardiol 2004; 36:295-304.
21. Schiffrin EL, Amiri F, Benkirane K, Iglarz M, Diep QN. Peroxisome proliferator-activated receptors vascular and cardiac effects in hypertension. Hypertension 2003; 42: 664-668.
22. Quy N, Diep FA, Karim B, Pierre P. Long-term effects of the PPARγ activator pioglitazone on cardiac inflammation in strokeprone spontaneously hypertensive rats. Can J Physiol Pharmacol 2004; 82: 976-985.